Diorganotin(IV) antitumor compound bis-[2,6-difluoro-N-(hydroxyl-<κ>O)benzamidato-<κ>O] (DBDF2,6T) was one of the novel patent organotin compounds with high antitumor activity and relatively low toxicity. In this study, several methods were used to study the interaction between DBDF2,6Tand hPPARc protein, including fluorescence quenching, three-dimensional (3D) fluorescence, drug affinity responsive target stability (DARTS), ultrafiltration-LC, and molecular docking. According to the experimental results, the quenching process of the hPPARc protein was induced by static quenching mode to form a nonradiative ground-state complex with DBDF2,6T spontaneously, mainly through the hydrophobic force. DBDF2,6T could bind to the hPPARc protein directly and give the protein the ability of antienzymatic hydrolysis. And the binding mode of DBDF2,6T into hPPARc protein appeared to have an orientation towards residues of SER342 and GLY284. In conclusion, these methods could comprehensively reveal the interaction details of DBDF2,6T and the hPPARc protein and established a feasible way to preliminarily identify the agonist compounds for the hPPARc protein.
Introduction
Organotin compounds have many uses in our life, which could act as stabilizers in plastics, fungicides, industrial catalysts, and so on. [1] . Our research group had synthesized a series of organotin patent compounds which possessed high anticancer activity with low toxicity and devoted to clarify its mechanism of action [2] . From the results of proteomics data, these compounds might play the physiological role through the PPAR (peroxisome proliferator-activated receptor) signaling pathway, which was consistent with the reports that organotin compounds may function as endocrine-disrupting chemicals by affecting the function of the protein PPARc [3] . Consequently, a reasonable hypothesis was made to assume that these biologically active compounds might function through the PPAR signaling pathway as an agonist to the protein PPARc and further influence the expressions of the target genes.
PPARs proteins belong to the most important members of the nuclear receptor superfamily and can act as the ligandactivated transcription factors [4] . When the PPARs proteins bind to a specific ligand, the ligand-binding domains of PPARs will encounter the conformational change followed by promoting the recruitment of nuclear receptor coregulators such as steroid rector coactivator-1 (SRC-1) and eventually influence the transcription of downstream target genes [5] . e PPARs proteins have three isotypes which had been identified as PPARα, PPARβ/δ, and PPARc. ese three subtypes exhibit distinct tissue distributions and have unique biological functions [6, 7] . In particular, PPARc has received much focus these years for the important physiological functions played by its ligands. For example, thiazolidinediones (TZDs), a class of PPARc agonist compounds, had been used as a therapeutic compound for metabolic disorders such as type 2 diabetes and obesity [8] , and it was also reported that the agonists to PPARc protein had a potential to be used as a new therapeutic approach to cancers, immune disorders, and so on. [9, 10] . erefore, the experiments established to find ligands which could interact with the PPARc protein are promising works nowadays.
In this study, a patent organotin compound DBDF2,6T (bis-[2,6-difluoro-N-(hydroxyl-<κ>O)benzamidato-<κ>O] dibutylitin) (patent number: CN200910074795.X and ZL01135148.9 (P)) which showed a high antitumor activity was assumed as a potential agonist. Several different methods were adopted to test and verify the interaction between DBDF2,6T and the hPPARc protein. Spectroscopic study, one of the most widely used methods for analyzing the interaction between small molecule and protein, was applied to provide parameters such as binding constants and types of interaction forces. DARTS and ultrafiltration-LC were used to verify such interaction while molecular docking was used to evaluate affinity between receptors and ligands in a theoretical way. ese methods meet the requirements of low cost and high feasibility and perfectly supplement and verify each other, which could be used to find the new agonists of the hPPARc protein preliminarily and offered references for the interaction analysis between synthesized compounds and proteins.
e structures of DBDF2,6T and the hPPARc protein are shown in Figure 1. 
Materials and Methods

Reagent. DBDF2,6T was synthesized by Shanxi Medical
University with purity over 99%. e protein human PPARc (hPPARc) was purchased from Flarebio Company (Flarebio Biotech LLC, Wu Han, China) and stored at −20°C. Pronase was purchased from Roche Diagnostic GmbH (Mannheim, Germany) and stored at 4°C. e Coomassie Blue R-250 was purchased from Sigma Company (Shanghai, China), and the PageRuler Prestained Protein Ladder was made by ermo Fisher Scientific (Massachusetts, America). e solvent of organotin(IV) was configured by propanediol (Tianjin Fengchuan Chemical Reagent Science and Technology Co., Tianjin, China), ethylenediamine, and normal saline (Shijiazhuang Pharmaceutical, Shijiazhuang, China) (90 : 9 : 1, v/v/v).
e disodium hydrogen phosphate dodecahydrate was purchased from Tianjin Fengchuan Chemical Reagent Company (Tianjin, China). e potassium phosphate monobasic was purchased from Tianjin Beichen Fangzheng Company (Tianjin, China).
All the other reagents used in this study were of analytical grade and were obtained commercially.
Fluorescence Quenching Spectrum.
Amino acid residues such as tryptophan, tyrosine, and phenylalanine could empower the proteins with the ability to generate endogenous fluorescence.
e fluorescence peaks of those three amino acids were located at 348 nm, 303 nm, and 282 nm, respectively. Actually, 95% of protein fluorescence was contributed to the tryptophan residue [11, 12] . Compared with other methods, fluorescence spectroscopy had many superior advantages including high sensitivity, selectivity, and easy operation [13] . erefore, in this paper, the fluorescence quenching method was used to analyze the interaction between DBDF2,6T and the hPPARc protein.
e experiments were performed at 293 K and 310 K on a U-3900 spectrofluorophotometer (BaHens Instrument Co. Ltd., China). Protein hPPARc (10 μg) was dissolved in a 2 mL PBS buffer. Several concentrations of DBDF2,6T (0.5 × 10 , 3.0 × 10 −6 , and 3.5 × 10 −6 mol/L) were, respectively, incubated with the certain concentration of the hPPARc protein. Samples of protein hPPARc and hPPARc-DBDF2,6T complexes were measured in a 1 cm 2 quartz cuvette. And the excitation and emission spectral slit widths were set as 10 nm. e emission spectra were recorded for light-scattering effects from 300 nm to 450 nm while the exciting wavelength was set as 280 nm. 
2.3.
ree-Dimensional Fluorescence Spectrum. e coordinate axes of the three-dimensional (3D) fluorescence spectrum were excitation wavelength, emission wavelength, and fluorescence intensity. It had been proved that the 3D fluorescence spectrum was an effective analytical technique to analyze the conformation changes of a protein in its solution state [14] . And this method could not only test the molecular structure change with much selectivity and sensitivity but also display fluorescent information of the sample solution comprehensively [15] .
Experiments were performed at the temperature of 293 K. Protein hPPARc (10 μg) was dissolved in a 2 mL PBS buffer and incubated with 2.0 × 10 −6 mol/L DBDF2,6T for two minutes. Samples were tested on a U-3900 spectrofluorophotometer (BaHens Instrument Co. Ltd., China) with the parameters set as follows: excitation wavelength was from 200 nm to 300 nm; emission wavelength was from 320 nm to 450 nm; spectral slit width was 10 nm; and the gain value was 2.
DARTS with
Pure hPPARc Protein. DARTS had been proved to be an efficient approach to efficiently verify drugprotein interactions when the protein was available in relatively pure form [16] . e basic principle of DARTS was that compounds were proposed to stabilize the combined protein globally or locally by reducing protease sensitivity of the target protein. is phenomenon was attributed to a specific conformational change caused by such a binding process, which would further induce protease recognition sites of the protein to be masked [17] . In this study, protein hPPARc regarded as target protein and pure hPPARc protein generated from recombinant plasmid were used in this experiment. Whether the presence of DBDF2,6T could reduce the proteolysis of the protein to validate the interaction between protein hPPARc and DBDF2,6T should be observed after incubating the hPPARc protein with DBDF2,6T.
Eight sample groups were set and divided into blank group, negative control group, and test group; each sample contained 0.5 μg hPPARc protein. Except for the blank group, other samples were incubated with 2 μL DMSO or 2 μL DBDF2,6T with the concentration ranging from 1.0 × 10 −2 mol/L to 1.0 × 10 −4 mol/L for 60 min at 4°C and then digested with pronase (1 : 100) at room temperature for 30 min. e digestion was stopped by adding 5× SDS-PAGE sample loading buffer and boiling at 100°C for 10 min immediately. Samples were then subjected to electrophoresis on 8% SDS-PAGE. After electrophoresis, the gel was stained with Coomassie Brilliant Blue for 1 h and was observed after eluted overnight.
Ultrafiltration-Liquid Chromatography Experiment.
Ultrafiltration-liquid chromatography (ultrafiltration-LC) was developed to verify the agonists of protein hPPARc.
e main principle of ultrafiltration-LC was that the agonists of hPPARc had the ability to bind to the protein and would not be filtered out through the membrane of the ultrafiltration centrifuge tube, while after the protein denatured by dissolving in organic solvents, the compounds would be unbound to the protein and could be washed out through the membrane of the ultrafiltration centrifuge tube. Based on the ultraviolet absorption of the compound, the DBDF2,6T which were bound to hPPARc could be detected through analyzing the washed solution by liquid chromatography. is method was first used in such confirmatory experiment and marked by its simplicity, generality, and applicability [18] .
e recombination protein hPPARc (20 μg) was incubated with compound DBDF2,6T (2 μL·10 −3 mol/L) for 24 h at 4°C. After being filtered through a 10000 Da molecular weight cutoff ultrafiltration membrane (Millipore, UFC500396) by centrifugation at 13000 r/min for 8 min at 4°C, the sample was washed three times with 150 μL PBS buffer (pH 7.4) and centrifuged at 13000 r/min for 12 min at 4°C to remove the unbond compounds. e washed solution was transferred to a new 10000 Da molecular weight cutoff ultrafiltration centrifuge tube and dissolved it in 400 μL methanol. Centrifugation at 13000 r/min for 12 min was performed to wash out the compounds which were combined with the protein, and the washed solution was collected. Following reconstitution in 100 μL of 50% aqueous methanol, the compound was analyzed using HPLC (Agilent Technologies). Denatured protein was used as a negative control, and in this experiment, the protein was heated at 98°C for 15 min to make it denatured.
e HPLC analysis was carried out using mobile phase methanol/0.5% phosphoric acid (28 : 72, v/v, pH 3.0) on a C18 column (Agilent TC-C18, 4.6 × 250 mm i.d., 5 μm) at a flow rate of 0.8 mL/min and at 25°C. e detection wavelength was set at 264 nm.
Molecular Docking.
Surflex-Dock, docking module in SYBYL software (UCSF), was performed to determine the binding model of protein hPPARc (4a4w.pdb) and DBDF2,6T. It used prototype molecule (protomal) to represent protein binding pocket, utilizing probe to test the qualities of protein pocket such as surface hydrophobicity and could generate the invert transform of an active protein pocket. is method had high docking accuracy and could be used to research on the interaction between biomacromolecules and small molecular ligands [19] .
Sybly × 2.0 was used to draw two-dimensional structure of DBDF2,6T with standard bonds and angles. In the process of optimizing the compound structure, minimize details and parameters of modify were set as follows. Minimize details: the iterations were set as 10000, and the color option was set as force. Parameters of modify: the force field was set as Tripos and the charges were set as Gasteiger-Marsili. In the docking process, A/YFB99 was chosen as extracted ligand structure and hydrogen molecules were added to the protein, and the modify details were set as follows: the force field was AMBER7 FF99 and the charge was AMBER. All other parameters were used the default value of SYBYL during the protein pocket generation and the molecular docking.
Results and Discussions
Fluorescence Spectrum of Protein hPPARc and hPPARc-DBDF2,6T
Complexes. Fluorescence curves of the protein Bioinorganic Chemistry and ApplicationshPPARc and hPPARc-DBDF2,6T complexes are shown in Figure 2 .
e experiments were carried out in two temperatures with other experimental conditions unchanged. It can be observed from Figure 2 that, in both the experimental system of 273 K and 310 K, the intensity of fluorescence of the hPPARc protein was decreased while increasing the concentration of DBDF2,6T which was incubated with the hPPARc protein. And the highest fluorescent intensity values of hPPARc were recorded for next step of theoretical calculation.
Mechanism of Fluorescence Quenching.
While the pH, temperature, and ionic strength were kept as constants, the types of fluorescence quenching could be classified into two categories: dynamic quenching and static quenching [20] . Dynamic quenching was caused by the fluorescent chromophore interacted with a quencher in excitation state, while the causes of static quenching were of three types: the first one, the fluorescent chromophore interacted with a quencher in ground state and came into being a nonfluorescent compound; the second one, the medium near the fluorescent chromophore had a polarity change, which caused by the conformational change of the protein attributing to the combination with the quencher; and the third one, a radiationless energy transfer between the fluorescent chromophore and the quencher [21] .
e dynamic quenching obeyed the Stern-Volmer equation, and the formulas are shown as follows:
where K SV is the Stern-Volmer quenching constant, K q is the bimolecular quenching constant, and τ 0 is the average lifetime of the molecule which always be considered as 1.0 × 10 e Stern-Volmer quenching curves were drawn according to the data obtained from fluorescence quenching spectra, and the corresponding linear regression equations and correlation coefficients are shown in Table 1 .
When a quencher interacted with a biomacromolecule, the maximum value of diffusion collision rate constant was considered as 2.0 × 10 10 L/mol/s. According to the computing results shown in Table 1 , the dynamic quenching constant (K q ) between DBDF2,6T and the hPPARc protein was of the order of magnitude of 10 12 , which was much bigger than the maximum value of diffusion collision rate constant. Consequently, the type of fluorescence quenching of the hPPARc protein induced by DBDF2,6T was preliminary defined as a kind of static quenching [24] . In dynamic quenching, which was associated with diffusion, quenching constant of fluorescent material was increasing as the temperature increased. But from the Figure 3 , the slope of the Stern-Volmer lines was decreased while increasing the temperature of the experimental system, which further confirmed the quenching mechanism of DBDF2,6T with the hPPARc protein was static quenching.
Binding Constants and Binding Site Numbers.
Equation (2) is the Lineweaver-Burk double-reciprocal equation, and (3) was deduced by (2) [25] :
where K A is the binding constant and n is the number of independent binding sites. When −lg[F 0 − F/F] were plotted against lgc(Q), a straight line could be drawn and is shown in Figure 4 . e corresponding computing results are shown in Table 2 . In both the experimental temperatures (273 K and 310 K), the computing binding site numbers were near to 1, which meant that the hPPARc-DBDF2,6T complexes were formed by protein hPPARc and DBDF2,6T at the ratio approximately to 1 : 1. And the binding constants were of the order of magnitude of 10 3 , which meant that the binding ability between them was pretty strong.
3.4.
ermodynamic Parameters and Interaction Forces. e interaction forces between small molecules and biomacromolecules were belonged to noncovalent force including hydrogen bond, van der Waals force, electrostatic attraction, and so on. e main acting force between hPPARc protein and DBDF2,6T could be judged according to the thermodynamic parameters which were calculated based on the Van't Hoff equation [26] . From the previous researches on interaction abilities, it was assumed that different proteins and compounds had different main acting force [27] . e thermodynamic parameters were calculated according to following equations:
where R is the gas constant, ΔG is the Gibbs free energy change, ΔS is the entropy change, ΔH is the enthalpy change, and K is the Stern-Volmer quenching constant. ΔH could be considered as a constant when the temperature changed in small range. And the Ross law indicated that, if ΔH > 0 and ΔS > 0, the main acting force between small molecules and biomacromolecules would be hydrophobic force; if ΔH < 0 and ΔS < 0, it would be hydrogen bond and van der Waals force; and if ΔH ≈ 0 and ΔS > 0, it would be electrostatic force [28] . According to the computing results shown in Table 3 , ΔH was 19.03 kJ/mol, ΔS was 3.92 J/mol·K and 3.90 J/mol·K correspondingly at 293 K and 310 K, and ΔG was −20.18 kJ/mol and −20.24 kJ/mol correspondingly at 293 K and 310 K. Based on the Ross law, the main acting force between hPPARc protein and DBDF2,6T was hydrophobic force. In addition, the regulator effect of several kinds of interaction forces and relevant microenvironments were both responsible for the macroscopic consequence [29] .
Conformational Change of hPPARc Protein.
e 3D fluorescence spectrum is shown in Figure 5 in the form of intensive contour map. e related data are shown in Table 4 .
It can be observed from Figure 5 that two typical fluorescence peaks of proteins were located approximately at λ em � 340 nm. In order to observe the peaks of fluorescent groups more clearly, the excitation wavelength range was set smaller than emission wavelength range, so the spectra of Rayleigh scattering were not available on the picture [19] . After the hPPARc protein was incubated with DBDF2,6T, the location of both fluorescence peaks did not show a significant change, but the intensity of each peak was reduced at different degrees. From the 3D fluorescence spectra of the hPPARc protein ( Figure 5(a) ), the intensity ratio of the big peak to the small one was 7.97 : 1, while after the protein was incubated with DBDF2,6T ( Figure 5(b) ), the value was changed to 8.00 : 1, and the DBDF2,6T showed a strong quenching effect on the big peak which was located at about 290/340 (λ ex /λ em ). e 3D fluorescence spectrum indicated a conformational change of the specific structures of the hPPARc protein, which could further validate the interaction between the hPPARc protein and DBDF2,6T [30] .
Confirmation of the Interaction Ability Using DARTS
Technique. To identify the binding targets for small molecules, the key advantage of DARTS method was no sample pretreatments such as labeling the ligand [17] . And the method was particularly useful when a compound had a lower affinity with the target, even the binding constant was in micromolar range [31] . To confirm the feasibility of the DARTS applying to the hPPARc protein, a preliminary experiment had been performed to research the digestion effects of the protease on the hPPARc protein. And the pronase was used for digestion because it had been proved to be more useful for DARTS than any other protease [16] . In preliminary experiment, the digestion effects of time of enzymolysis and the concentration of pronase had been investigated. After electrophoresis and staining, the protein bands of each sample are shown in Figure 6 . Compared with the DMSO control, under certain conditions, the antienzymatic hydrolysis ability of hPPARc protein did exist and was closely related to the concentration of DBDF2,6T incubated with the protein. In 0.5 × 10 −4 mol/L DBDF2,6T, the strongest antienzymatic hydrolysis ability of the hPPARc protein would appear, and such ability could be weakened with the change in the concentration. Although DBDF2,6T had shown hydrolysis ability to the hPPARc protein at relatively high concentration, the protective functions of DBDF2,6T to the hPPARc protein still could be observed and existed concentration-effect relationships in some extent. Consequently, the interaction between hPPARc protein and DBDF2,6T could be indirectly verified [32] .
Confirmation of the Binding Ability Using Ultrafiltration-LC Technique.
e results of ultrafiltration-LC experiment are shown in Figure 7 . It can be observed from the chromatograms that both the sample and the negative control had an obvious peak at location about 8.75 min which belongs to compound DBDF2,6T. Significant signal enhancement of the peak of compound DBDF2,6T between the sample and the negative control indicated a specific binding between DBDF2,6T and the recombinant protein hPPARc, while the signal of DBDF2,6T in the negative control was attributed to the nonspecific binding [33] . e big impurity peak was located at about 7 min attributed to the solution of recombination protein hPPARc. erefore, the experiment of ultrafiltration-LC did verify that compound DBDF2,6T could bind to pure protein hPPARc directly in physiological environment [34] .
Exploration of the
eoretical Binding Details Using Molecular Docking. In order to further understand the interaction between DBDF2,6T and hPPARc protein, molecular docking was used to explore the theoretical binding details of them [35] . Among the docking of 12 conformers of DBDF2,6T to generate pocket of the hPPARc protein, the highest total score was 7.14 and the corresponding crash score and polar score were −1.86 and 0.00, respectively, which meant that DBDF2,6T had a pretty strong affinity to hPPARc protein, and such docking process was under a relatively comfortable level of molecules [36] . e generated pocket of hPPARc is shown in Figure 8(a) , and the hydrogen bond graph is shown in Figure 8 (b). In conclusion, DBDF2,6T could theoretically bind to hPPARc protein with pretty strong binding strength, and it could directly interact with SER342 and GLY284 of hPPARc protein by hydrogen bond. e hydrogen bond lengths between DBDF2,6T and SER342 were 2.50Å and 2.42Å, and that between DBDF2,6T and GLY284 was 2.74Å. 
Conclusions
is study analyzed the interaction between the novel patent organotin compound DBDF2,6T and the hPPARc protein under physiological condition with the methods of fluorescence quenching, 3D fluorescence, DARTS, ultrafiltration-LC, and computer molecular docking. According to the spectroscopic experimental data, DBDF2,6T could interact with the hPPARc protein and formed a nonradiative ground-state complex of hPPARc-DBDF2,6T, mainly through hydrophobic force. Such a reaction was spontaneous and could cause a conformational change of the hPPARc protein. And the experiments of DARTS and ultrafiltration-LC preliminarily proved the possibility of DBDF2,6T to be an agonist compound to hPPARc protein.
Considering the anticancer activity of DBDF2,6T and various physiological functions performed by agonists of PPARc protein, the conclusion could be drawn that DBDF2,6T had a possibility to interact with the hPPARc protein as an agonist and finally inducing physiological effects such as anticancer activity. is work successfully revealed the interaction of DBDF2,6T with hPPARc protein and established a feasible way to validate the agonist compounds for hPPARc protein. Human peroxisome proliferatoractivated receptor gamma 3D fluorescence:
ree-dimensional fluorescence DARTS:
Drug affinity responsive target stability LC:
Liquid chromatography.
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